Total Payments
$11,731
2023 Payments
$13.49
Companies
5
Transactions
22
Payment Breakdown by Category
Other$7,750 (66.1%)
Travel$2,714 (23.1%)
Research$867.00 (7.4%)
Food & Beverage$258.52 (2.2%)
Consulting$141.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $7,750 | 3 | 66.1% |
| Travel and Lodging | $2,714 | 4 | 23.1% |
| Unspecified | $867.00 | 8 | 7.4% |
| Food and Beverage | $258.52 | 6 | 2.2% |
| Consulting Fee | $141.00 | 1 | 1.2% |
Payments by Type
General
$10,864
14 transactions
Research
$867.00
8 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ALCRESTA THERAPEUTICS, INC. | $10,682 | 11 | $0 (2019) |
| AbbVie Inc. | $846.00 | 6 | $0 (2020) |
| Janssen Research & Development, LLC | $162.00 | 3 | $0 (2017) |
| VERTEX PHARMACEUTICALS INCORPORATED | $27.40 | 1 | $0 (2020) |
| PARI Respiratory Equipment, Inc. | $13.49 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $13.49 | 1 | PARI Respiratory Equipment, Inc. ($13.49) |
| 2020 | $309.40 | 3 | AbbVie Inc. ($282.00) |
| 2019 | $6,257 | 8 | ALCRESTA THERAPEUTICS, INC. ($5,975) |
| 2018 | $4,707 | 5 | Alcresta Therapeutics, Inc. ($4,707) |
| 2017 | $444.00 | 5 | AbbVie, Inc. ($282.00) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/22/2023 | PARI Respiratory Equipment, Inc. | Kitabis Pak (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Cystic Fibrosis | ||||||
| 09/02/2020 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $27.40 | General |
| 04/09/2020 | AbbVie Inc. | CREON (Drug) | — | Cash or cash equivalent | $141.00 | Research |
| Study: P12-792 • Category: ENDOCRINOLOGY | ||||||
| 02/21/2020 | AbbVie Inc. | CREON (Drug) | — | Cash or cash equivalent | $141.00 | Research |
| Study: P12-792 • Category: ENDOCRINOLOGY | ||||||
| 09/25/2019 | AbbVie, Inc. | Creon (Drug) | — | Cash or cash equivalent | $141.00 | Research |
| Study: P12-792 • Category: Endocrinology | ||||||
| 02/27/2019 | AbbVie, Inc. | Creon (Drug) | — | Cash or cash equivalent | $141.00 | Research |
| Study: P12-792 • Category: Endocrinology | ||||||
| 02/01/2019 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2019 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2019 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Travel and Lodging | In-kind items and services | $1,523.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2019 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $100.32 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2019 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Travel and Lodging | Cash or cash equivalent | $75.96 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/24/2019 | ALCRESTA THERAPEUTICS, INC. | RELIZORB (Device) | Food and Beverage | Cash or cash equivalent | $25.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2018 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2018 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Travel and Lodging | Cash or cash equivalent | $1,015.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2018 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Travel and Lodging | Cash or cash equivalent | $99.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2018 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | Cash or cash equivalent | $73.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2018 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/12/2017 | Janssen Research & Development, LLC | PANCREAZE (Drug) | — | Cash or cash equivalent | $54.00 | Research |
| Study: A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement • Category: R&D Compound | ||||||
| 06/14/2017 | AbbVie, Inc. | Creon (Drug) | — | Cash or cash equivalent | $141.00 | Research |
| Study: P12-792 • Category: Endocrinology | ||||||
| 06/14/2017 | Janssen Research & Development, LLC | PANCREAZE (Drug) | — | Cash or cash equivalent | $54.00 | Research |
| Study: A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement • Category: R&D Compound | ||||||
| 02/15/2017 | AbbVie, Inc. | Creon (Drug) | Consulting Fee | Cash or cash equivalent | $141.00 | General |
| Category: Endocrinology | ||||||
| 02/15/2017 | Janssen Research & Development, LLC | PANCREAZE (Drug) | — | Cash or cash equivalent | $54.00 | Research |
| Study: A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement • Category: R&D Compound | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| P12-792 | AbbVie, Inc. | $423.00 | 3 |
| P12-792 | AbbVie Inc. | $282.00 | 2 |
| A Long-Term Prospective Observational Safety Study of the Incidence of and Risk Factors for Fibrosing Colonopathy in US Patients with Cystic Fibrosis Treated with Pancreatic Enzyme Replacement | Janssen Research & Development, LLC | $162.00 | 3 |
About Dr. John Stevens, MD
Dr. John Stevens, MD is a Pediatric Pulmonology healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053404947.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Stevens, MD has received a total of $11,731 in payments from pharmaceutical and medical device companies, with $13.49 received in 2023. These payments were reported across 22 transactions from 5 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($7,750).
Ad
Practice Information
- Specialty Pediatric Pulmonology
- Location Indianapolis, IN
- Active Since 10/02/2006
- Last Updated 02/06/2026
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1053404947
Products in Payments
- RELIZORB (Device) $10,682
- Creon (Drug) $564.00
- CREON (Drug) $282.00
- PANCREAZE (Drug) $162.00
- Kitabis Pak (Drug) $13.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Pulmonology Doctors in Indianapolis
Dr. Clement Ren, Md, MD
Pediatric Pulmonology — Payments: $36,618
Pediatric Pulmonology $36,618
Don Sanders
Pediatric Pulmonology — Payments: $7,227
Pediatric Pulmonology $7,227
Gregory Montgomery, Md, MD
Pediatric Pulmonology — Payments: $2,119
Pediatric Pulmonology $2,119
Dr. Nadia Krupp, M.d, M.D
Pediatric Pulmonology — Payments: $1,464
Pediatric Pulmonology $1,464
James Chmiel, Md, MD
Pediatric Pulmonology — Payments: $1,202
Pediatric Pulmonology $1,202
Dr. Sandeep Puranik, M.d, M.D
Pediatric Pulmonology — Payments: $1,173
Pediatric Pulmonology $1,173